arrow
W

William H. Fissell

University of Alberta
H指数:39
被引数:7,682

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An integrative roadmap for a new era of kidney replacement therapies

肾脏替代治疗新纪元的一体化路线图

2026-11-060
PRE
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis

囊性纤维化患者中头孢吡肟,美罗培南和哌拉西林-他唑巴坦的群体药代动力学模型

2024-09-300
PRE
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients

群体药代动力学和目标达成分析,以确定重症患者头孢吡肟的合理经验给药策略

2023-04-183
OA
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis

基于群体药代动力学模型与目标达标分析对重症监护病房患者美罗培南经验性给药方案的评价

2023-01-248
OA
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets

Supermeres是充满疾病生物标志物和治疗靶点的功能性细胞外纳米颗粒

2021-12-09219
OAAI